✦ LIBER ✦

Successful treatment of acute hepatitis C virus in HIV positive patients using the European AIDS Treatment Network guidelines for treatment duration

✍ Scribed by Jienchi Dorward; Nigel Garrett; Duncan Scott; Matthew Buckland; Chloe Orkin; Guy Baily

Book ID: 116632171
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 190 KB
Volume: 52
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2011.08.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal duration of treatment for acute

Optimal duration of treatment for acute hepatitis c in human immunodeficiency virus–positive individuals?

✍ Gail V. Matthews; Gregory J. Dore 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

European AIDS Clinical Society (EACS) gu

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults

✍ JK Rockstroh; S Bhagani; Y Benhamou; R Bruno; S Mauss; L Peters; M Puoti; V Sori 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Characteristics of substance abuse treat

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

✍ Lawrence S. Brown Jr.; Steven Allan Kritz; R. Jeffrey Goldsmith; Edmund J. Bini; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB

2011 Japanese Society for Dialysis Thera

2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients

✍ Takashi Akiba; Kazuhiko Hora; Michio Imawari; Chifumi Sato; Eiji Tanaka; Namiki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Positive impact of hepatitis C virus (HC

Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus–HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users

✍ Perrine Roux; Lionel Fugon; Maria Winnock; Dominique Salmon-Céron; Karine Lacomb 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Boceprevir versus placebo with pegylated

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

✍ Sulkowski, Mark; Pol, Stanislas; Mallolas, Josep; Fainboim, Hugo; Cooper, Curtis 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 333 KB